Agonistic anti-cd40 promotes early development and increases the incidence of severe thyroid epithelial cell hyperplasia (Tec h/p) in cd4 / mice

Immunity, Inflammation and Disease

Volumn 1, Issue 1, 2013, Pages 14-25

  Yu, Shiguang ^a,b,c   Downey, Edward F ^b   Braley Mullen, Helen ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b University of Missouri   (United States)

^c ARKANSAS STATE UNIVERSITY   (United States)

Author keywords

Autoimmunity; Fibrosis; Hyperplasia; Inflammation; T cells

Indexed keywords

EID: 84988976899     PISSN: None     EISSN: 20504527     Source Type: Journal    
DOI: 10.1002/iid3.5     Document Type: Article

References (44)

1. Yu, S., G. C. Sharp, and H. Braley-Mullen. 2002. Dual roles for IFN-γ, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Immunol. 169:3999–4007.
2. Yu, S., G. C. Sharp, and H. Braley-Mullen. 2006. Thyrocyte hyperplasia in IFN-γ-deficient NOD. H-2h4 mice. Clin. Immunol. 118:92–100.
3. DeMay, R. 2000. Follicular lesions of the thyroid: w(h)ither follicular carcinoma? Am. J. Clin. Pathol. 114:681–683.
4. Derwahl, M., and H. Studer. 2002. Hyperplasia versus adenoma in endocrine tissues: are they different? Trends Endocrinol. Metab. 13:23–28.
5. Baloch, Z., and V. A. LiVolsi. 2002. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am. J. Clin. Pathol. 117:143–150.
6. Singh, R. R. 2005. SLE: translating lessons from model systems to human disease. Trends Immunol. 26:572–579.
7. Gabrielli, A., E. V. Avvedmento, and T. Krieg. 2009. Mechanism of diseases: scleroderma. New Engl. J. Med. 360:1989–2003.
8. Asa, S. L. 2004. My approach to oncocytic tumours of the thyroid. J. Clin. Pathol. 57:225–232.
9. DeMay, R. M. 2000. Follicular lesions of the thyroid. W(h) ither follicular carcinoma? Am. J. Clin. Pathol. 114:681–683.
10. Yu, S., Y. Fang, T. Sharav, G. C. Sharp, and H. Braley-Mullen. 2011. CD8+ T cells induce thyroid epithelial cell hyperplasia and fibrosis. J. Immunol. 186:2655–2662.
11. West, E. E., B. Youngblood, W. G. Tan, et al. Tight regulation of memory CD8+ T cells limits their effectiveness during sustained high viral load. Immunity 2011;35:285–298.
12. Belz, G. T., D. Wodarz, G. Diaz, and P. C. Doherty. 2002. Compromised influenza virus-specific CD8+ T cell memory in CD4+ T cell-deficient mice. J. Virol. 76:12388–12393.
13. + T lymphocytes. Nature 421:852–865.
14. Blachere, N. E., H. K. Morris, D. Braun, H. Saklani, J. Di Santo, R. B. Darnell, and M. L. Albert. 2006. IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J. Immunol. 176:7288–7300.
15. Shameli, A., X. Clementle-Casares, J. Wang, and P. Santamaria. 2011. Development of memory-like autoregula-tory CD8+ T cells is CD4+ T cell dependent. J. Immunol. 187:2859–2866.
16. Yang, G., Y. Wu, H. Tsukamoto, et al. 2011. CD8 T cells mediate direct biliary ductile damage in nonobese diabetic autoimmune biliary disease. J. Immunol. 186:1259–1267.
17. Chen, K., Y. Wei, G. C. Sharp, and H. Braley-Mullen. 2007. Decreasing TNF-α results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroidtis. J. Leuk. Biol. 81:306–314.
18. Fang, Y., S. Yu, and H. Braley-Mullen. 2012. TGF-β promotes proliferation of thyroid epithelial cells in IFN-γ / mice by down-regulation of p21 and p27 via AKT pathway. Am. J. Pathol. 180:650–660.
19. Yu, S., G. C. Sharp, and H. Braley-Mullen. 2008. TGF-β promotes thyroid epithelial cell hyperplasia and fibrosis in IFN-γ deficient NOD.H-2h4 mice. J. Immunol. 181:2238– 2245.
20. Sarawar, S. R., B. J. Lee, S. K. Reiter, and S. P. Schoenberger. 2001. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of latent hypervirus. Proc. Nat. Acad. Sci. USA. 98:6325–6329.
21. Hernandez, M., L. Shen, and K. L. Rock. 2007. CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help. J. Immunol. 178:2844–2852.
22. French, R. R., H. T. Chan, A. L. Tutt, and M. J. Glennie. 1999. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma andbypasses T-cell help. Nat. Med. 5:548–553.
23. Ridge, J. P., F. D. Rosa, and P. A. Matzinger. 1998. Conditioned dendritic cell can be a bridge between a CD4+ T-helper and T-killer cell. Nature 393:474–478.
24. Zafirova, B., F. M. Wensveen, M. Gulin, and B. Polic. 2011. Regulation of immune cell function and differentiation by the NKG2D receptor. Cell. Mol. Life Sci. 68:3519–3529.
25. Zhu, J., Y. Hidehiro, and P. E. William. 2010. Differentiation of effector CD4 T cell populations. Ann. Rev. Immunol. 28:445–489.
26. Bevan, M. J. 2004. Helping the CD8+ T-cell response. Nat. Rev. Immunol. 4:595–602.
27. Williams, M. A. and M. J. Bevan. 2007. Effector and memory CTL differentiation. Ann. Rev. Immunol. 25:171–192.
28. Johnson, S., Y. Zhan, R. M. Sutherland, et al. 2009. Selected Toll-like receptor ligands and viruses promote helper-helper- independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity 30:218–227. independent
29. Grewal, I. S. and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Ann. Rev. Immunol. 16:111–135.
30. Elgueta, R., M. J. Benson, V. C. deVries, A. Wasiuk, Y. Guo, and R. J. Noelle. 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229:152–172.
31. Uhlig, H. H. B. S. McKenzle, S. Hue, et al. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309–318.
32. Lode, H. N., R. Xiang, U. Pert, E. Forster, S. P. Schoenberger, S. D. Gillies, and R. A. Reisfeld. 2000. Melanoma immuno-therapy by targeted IL-2 depends on CD4+ T-cell help mediated by CD40/CD40L interaction. J. Clin. Invest. 105:1623–1630.
33. Mehling, A., K. Loser, G. Varga, D. Metze, T. A. Luger, T. Schwartz, S. Grabbe, and S. Beissert. 2001. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194:615–628.
34. Baker, R. L. T. Mallevaey, L. Gapin, and K. Haskins. 2012. T cells interact with T cells via CD40-CD154 to promote autoimmunity in type 1 diabetes. Eur. J. Immunol. 42:672– 680.
35. Carter, J., G. M. Vaitaitis, D. M. Waid, and D. H. Wagner Jr. 2012. CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts tolerance. Eur. J. Immunol. 42:424–435.
36. Khanolkar, A., M. J. Fuller, and A. J. Zajac. 2004. CD4 T cell-dependent CD8 T cell maturation. J. Immunol. 172:2834– 2844.
37. Koschella, M., D. Voehringer, and H. Pircher. 2004. CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells. J. Immunol. 172:4804–4811.
38. Amrani, A., P. Serra, J. Yamanouchi, B. Han, S. Thiessen, J. Verdaguer, and P. Santamaria. 2002. CD154-dependent priming of diabetogenic CD4+ T cells dissociated from activation of antigen-presenting cells. Immunity 16:719– 732.
39. Liblau, R. S., F. S. Wong, L. T. Mars, and P. Santamaria. 2002. Autoreactive CD8T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17:1–6.
40. Kayes, T. Y. Fang, S. Yu, E. Downey, S. Wang, and H. Braley-Mullen. 2013. Agonistic anti-CD40 induces thyrocyte proliferation and promotes thyroid autoimmunity by increasing CD40 expression on thyroid epithelial cells. J. Immunol. 190:3928–3938.
41. Huseby, E. S., D. Liggitt, T. Brabb, B. Schnabel, C. Ohlen, and J. A. Goverman. 2001. A pathogenic role for myelin-specific CD8 (+) T cells in a model for multiple sclerosis. J. Exp. Med. 194:669–676.
42. Corse, E., R. A. Gottschalk, J. S. Park, M. A. Sepulveda, P. Loke, T. J. Sullivan, L. A. Johnson, and J. P. Allison. 2013. Chronic inflammatory liver disease in mice expressing a CD28-specific ligand. J. Immunol. 190:526–530.
43. Roth, E., F. Schwartzkopff, and H. Pircher. 2002. CD40 ligation in the presence of self-reactive CD8 T cells leads to severe immunopathology. J. Immunol. 168:5124– 5129.
44. Huber, A. K., F. D. Finkelman, C. W. Li, et al. 2012. Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J. Immunol. 189:3043–3053.